These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30561164)

  • 1. Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques.
    van Dijken BRJ; van Laar PJ; Smits M; Dankbaar JW; Enting RH; van der Hoorn A
    J Magn Reson Imaging; 2019 Jan; 49(1):11-22. PubMed ID: 30561164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
    Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
    Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
    Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
    J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative histopathologic assessment of perfusion MRI as a marker of glioblastoma cell infiltration in and beyond the peritumoral edema region.
    Vallatos A; Al-Mubarak HFI; Birch JL; Galllagher L; Mullin JM; Gilmour L; Holmes WM; Chalmers AJ
    J Magn Reson Imaging; 2019 Aug; 50(2):529-540. PubMed ID: 30569620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
    Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
    Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular architecture mapping for early detection of glioblastoma recurrence.
    Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
    Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI.
    Jung BC; Arevalo-Perez J; Lyo JK; Holodny AI; Karimi S; Young RJ; Peck KK
    J Neuroimaging; 2016; 26(2):240-6. PubMed ID: 26235208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.
    Suh CH; Kim HS; Choi YJ; Kim N; Kim SJ
    AJNR Am J Neuroradiol; 2013 Dec; 34(12):2278-86. PubMed ID: 23828115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.
    Chawla S; Wang S; Mohan S; Nasrallah M; Verma G; Brem S; O'Rourke DM; Wolf RL; Poptani H; Nabavizadeh SA
    J Magn Reson Imaging; 2019 Jan; 49(1):184-194. PubMed ID: 29676844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.
    Strauss SB; Meng A; Ebani EJ; Chiang GC
    Neuroimaging Clin N Am; 2021 Feb; 31(1):103-120. PubMed ID: 33220823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts and challenges in the radiologic assessment of brain tumors in children: part 2.
    Tamrazi B; Mankad K; Nelson M; D'Arco F
    Pediatr Radiol; 2018 Dec; 48(13):1844-1860. PubMed ID: 30215111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating tumor perfusion by hyperpolarized
    Park I; von Morze C; Lupo JM; Ardenkjaer-Larsen JH; Kadambi A; Vigneron DB; Nelson SJ
    Magn Reson Med; 2017 Feb; 77(2):841-847. PubMed ID: 26892398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma.
    Gonçalves FG; Chawla S; Mohan S
    J Magn Reson Imaging; 2020 Oct; 52(4):978-997. PubMed ID: 32190946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma.
    Manning P; Daghighi S; Rajaratnam MK; Parthiban S; Bahrami N; Dale AM; Bolar D; Piccioni DE; McDonald CR; Farid N
    J Neurooncol; 2020 May; 147(3):681-690. PubMed ID: 32239431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Clinical Brain Tumor Imaging.
    Villanueva-Meyer JE; Mabray MC; Cha S
    Neurosurgery; 2017 Sep; 81(3):397-415. PubMed ID: 28486641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.
    Larsson C; Groote I; Vardal J; Kleppestø M; Odland A; Brandal P; Due-Tønnessen P; Holme SS; Hope TR; Meling TR; Fosse E; Emblem KE; Bjørnerud A
    Magn Reson Imaging; 2020 May; 68():106-112. PubMed ID: 32004711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of the Posttherapeutic Brain.
    Telles BA; D'Amore F; Lerner A; Law M; Shiroishi MS
    Top Magn Reson Imaging; 2015 Jun; 24(3):147-54. PubMed ID: 26049818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
    Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI.
    Park JE; Kim HS; Park SY; Jung SC; Kim JH; Heo HY
    Radiology; 2020 May; 295(2):397-406. PubMed ID: 32154775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.